Logo_final_color.png
Industry Leader John Maraganore, Ph.D., Joins Cybrexa Therapeutics as Strategic Advisor
25 juin 2024 08h07 HE | Cybrexa Therapeutics
NEW HAVEN, Conn., June 25, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC)...
Logo_final_color.png
Cybrexa Regains Rights to CBX-12
06 févr. 2024 08h00 HE | Cybrexa Therapeutics
NEW HAVEN, Conn., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC)...
astex.png
Astex Expands Drug Discovery Collaboration With MSD
08 août 2023 04h00 HE | Astex Pharmaceuticals
CAMBRIDGE, United Kingdom, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule...
Growing Emphasis on Generic Drug Manufacturing Boosts Active Pharmaceutical Ingredient Market to US$ 300.2 Billion by 2033: Persistence Market Research
25 juil. 2023 14h33 HE | Persistence Market Research
New York, July 25, 2023 (GLOBE NEWSWIRE) -- Worldwide revenue from the active pharmaceutical ingredients market stands at US$ 192.3 Billion in 2022, with the global market estimated to surge ahead...
Logo_final_color.png
Cybrexa Therapeutics To Present Data at ASCO 2023 Highlighting First-In-Human, Dose-Finding Study of Lead Candidate CBX-12
25 mai 2023 17h01 HE | Cybrexa Therapeutics
Activity and Safety Profile Reinforces Potential of CBX-12 in Solid TumorsFour Objective Responses Observed in Breast and Ovarian Cancers with CBX-12Dose-Limiting Toxicity Identified as...
Logo_final_color.png
Cybrexa Appoints Jaya Gautam as Senior Vice President of Technical Operations
12 avr. 2023 08h00 HE | Cybrexa Therapeutics
NEW HAVEN, Conn., April 12, 2023 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC)...
logo 600X600.png
Global Bio analytical Testing Services Market to Surpass US$ 7,749.5 Million by 2030, Says Coherent Market Insights (CMI)
24 janv. 2023 09h15 HE | CMI
Burlingame, Jan. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global bio analytical testing services market is estimated to be valued at US$ 3,198.9  million in 2022 and is...
MicrosoftTeams-image (5).png
AI in Drug Discovery Market to Rise at 36.1% CAGR during Forecast Period: TMR Study
03 oct. 2022 06h30 HE | Transparency Market Research
Wilmington, Delaware, United States, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – By 2031, the AI in drug discovery market size is estimated to surpass value of US$ 10.93...
Research Nester  Logo
Global Regenerative Medicine Market to Touch USD 167500.0 Million by 2029; Increasing Incidences of Cancer and Other Chronic Diseases to Create Opportunities for Market Growth
30 nov. 2021 08h56 HE | Research Nester
New York, Nov. 30, 2021 (GLOBE NEWSWIRE) -- According to the statistics by the American Institute of Cancer Research, the total number of new cases of cancer diagnosed worldwide in the year 2018 was...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Reports Inducement Grants For New Staff
06 oct. 2021 07h00 HE | Recro Pharma, Inc.
EXTON, Penn. and SAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...